top of page
Search

Malaysia: NPRA’s New Protocol Assessment and Testing Procedure for Registered Vaccine Products
The National Pharmaceutical Regulatory Agency (NPRA) is set to introduce key initiative aimed at strengthening the quality monitoring of...
ARQon
Jan 132 min read

China: New Updates for Pharmaceutical Excipients and Packaging Materials Appendices to GMP (w.e.f. 1 January 2026)
The State Drug Administration of China has released an important update aimed at strengthening the quality management of pharmaceutical...
ARQon
Jan 82 min read

Indonesia: Dried Blood Spot (DBS) Products Now Classified as Medical Devices (w.e.f. 9 December 2024)
Recently, the Ministry of Health of Indonesia announced that Kertas Saring, also known as Dried Blood Spot (DBS) , will be recognized as...
ARQon
Dec 30, 20242 min read

Malaysia: NPRA's Transition to Remote GDP Inspections (w.e.f. 18 December 2024)
The National Pharmaceutical Regulatory Agency (NPRA) has introduced a progressive initiative to improve the regulatory process for...
ARQon
Dec 26, 20242 min read

France: Navigating Clinical Trial Compliance Before the January 2025 Deadline
On 31 January 2022, European Regulation No. 536/2014 (CER) on clinical trials of medicinal products officially came into force, replacing...
ARQon
Dec 24, 20242 min read

Indonesia: Online Certification and Medical Device Licensing Systems to Close Temporarily
The Ministry of Health of Indonesia has temporarily closed the Medical Device Licensing and Online Certification Systems for scheduled...
ARQon
Dec 23, 20242 min read

Australia: TGA Updates Labeling Requirements and Guidelines for Injectable Medicines
The Therapeutic Goods Administration (TGA) has announced updates to the labeling requirements and guidelines for injectable electrolyte...
ARQon
Dec 18, 20242 min read

Philippines: Comprehensive Framework for FDA LTO Application of Covered Health Product Establishments
On 22nd November 2024, the Department of Health of the Republic of the Philippines issued Administrative Order No. 2024-0015 , aiming to...
ARQon
Dec 17, 20242 min read

Singapore: HSA Launches Pilot for Change Management Program (CMP) Targeting SaMD and AI-Driven Innovations (w.e.f 4 December 2024)
Singapore's Health Sciences Authority (HSA) is taking a significant step toward modernizing regulatory frameworks with its pilot for the...
ARQon
Dec 11, 20241 min read

China: NMPA Introduces Interim Provisions on Domestic Responsible Persons Designated by Overseas Drug Marketing Authorization Holders (w.e.f 1 July 2025)
To enforce the Drug Administration Law of the People’s Republic of China and the Vaccine Administration Law of the People’s Republic of...
ARQon
Dec 10, 20242 min read

United Kingdom: MHRA Urges MAHs to Finalize Windsor Framework Adjustment
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a final call reminding marketing authorization holders...
ARQon
Dec 3, 20241 min read

Canada: Key Guidelines to Crafting an Effective CAPA Plan by Health Canada
Health Canada releases step-by-step guidance on developing an effective Corrective and Preventive Action Plan (CAPA), consisting of three...
ARQon
Dec 2, 20241 min read

Vietnam: Addressing Import License Expirations in Vietnam (by 25 December 2024)
On behalf of the Ministry of Health of Vietnam, the Infrastructure and Medical Device Administration (IMDA) has requested all related...
ARQon
Dec 2, 20241 min read

Malaysia: NPRA Bans Chloroform and Chloroform Spirit as Preservatives (w.e.f. 19 November 2024)
Effective 19 November 2024 , the National Pharmaceutical Regulatory Agency (NPRA) has issued Directive No. 16/2024, announcing the...
ARQon
Nov 27, 20242 min read

Australia: Key Deadlines for Patient-Matched Medical Devices (PMDDs)
The Therapeutics Goods Administration (TGA) has established a transition period to facilitate smooth transitions and allows continued...
ARQon
Nov 26, 20242 min read

Thailand: Guidelines for Document Referencing, Transfers, & Compliance in Medical Device Applications (w.e.f. 20 September 2024)
In alignment with the guidelines for licensing requests or notifications of medical device details by individuals, entities, or...
ARQon
Nov 20, 20242 min read

Nigeria: Zero VAT on Pharmaceuticals and Medical Devices
On the 9 October 2024, the Nigerian Federal Ministry of Health and Social Welfare has finalized an Executive Order implementing zero...
ARQon
Nov 13, 20241 min read

Indonesia: New Requirements for Medical Device Distributors Licensing Compliance (w.e.f 1 January 2025)
The Ministry of Health of Indonesia has introduced new guidelines for medical device distributors to enhance regulatory compliance,...
ARQon
Nov 12, 20241 min read

Belgium: Reminder End of Transition Period & Important Year-End Deadlines for Submitting Dossiers to the FAMHP
End of Transition Period for Clinical Trials FAHMP reminds all stakeholders, that starting from 31 January 2025 , all clinical trials...
ARQon
Nov 6, 20241 min read

Switzerland: Swissmedic Enhances Fast-Track and Temporary Authorization Processes for Human Medicine (w.e.f 15 Oct 2024)
Swissmedic, the Swiss regulatory authority for therapeutic products, has introduced updates to its guidance documents for the Fast-track...
ARQon
Nov 5, 20242 min read
bottom of page